Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

putting compounding of tirzepatide into a gray area. Meanwhile, semaglutide remains on the shortages list, but Novo Nordisk ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

The company received A+ for growth and profitability ... driven by strong revenue growth in its GLP-1 tirzepatide franchise - ...

Shares of Viking Therapeutics (NASDAQ: VKTX) fell on Monday, Nov. 4, despite some encouraging new data. Over the weekend, the ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

We recently compiled a list of the 10 Best Reddit Stocks To Buy Right Now. In this article, we are going to take a look at where Eli Lilly And Co.